Skip to content
Search

Latest Stories

Covid-19 vaccination indemnity cover of pharmacies extended until June 30

Vaccines deployment minister Nadhim Zahawi has extended the indemnity provided to the community pharmacies until June 30, 2021.

In a statement tabled in the parliament on Tuesday (Jan 19), the minister extended the indemnity provided to the community pharmacies further with an aim to push the Covid-19 vaccination drive in pharmacy sites and protect pharmacies with necessary indemnity cover.


The minister said in his statement: “Without adequate indemnity cover, pharmacies would be unable to commit to the programme. Their participation is crucial as they have been selected to fill geographical gaps in cover or where NHS capacity is such that they are unable to participate. Therefore, DHSC has provided a time limited clinical negligence indemnity to community pharmacy to June 30, 2021, to enable them to engage at pace with this programme.”

“The provision of such an indemnity enables pharmacy contractors to start to run services, whilst the Department and NHS England and Improvement continue to work with the community pharmacy sector on a longer-term approach to insuring community pharmacy for Covid-19 vaccinations.

“We had originally intended to time limit this to the end of March but with the decision to extend the period between vaccine doses, have decided to run the indemnity until the end of June.”

All claims of clinical negligence will be managed through the provider of the current state backed schemes – NHS Resolution - in line with the existing schemes.

The need for the indemnity was extremely urgent as pharmacy led centres could not begin to vaccinate patients until this was in place and indeed vaccinations have begun at six centres as of January 14, the minister said, adding, “delaying would have postponed the roll out of this vital aspect of the vaccination programme, restricting access to the vaccine in some areas of the county.

“We concluded that such a delay was not acceptable, and I hope it is clear why this was indeed a case of special urgency. Therefore, the normal 14 sitting days for consideration has on this occasion not been possible.”

The latest indemnity plan will cover clinical negligence, employer’s and public liability where a care provider seeking to become a ‘designated setting’ is unable to secure sufficient commercial insurance, or where an existing provider has been operating without sufficient cover.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less